Recent CMND News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/01/2024 04:15:19 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/26/2024 08:01:17 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/24/2024 08:30:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 08:10:02 PM
- Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy • GlobeNewswire Inc. • 09/16/2024 08:06:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/16/2024 08:01:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 08:01:18 PM
- Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment • GlobeNewswire Inc. • 09/12/2024 12:20:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/06/2024 08:01:30 PM
- Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment • GlobeNewswire Inc. • 09/06/2024 11:55:00 AM
- SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment • GlobeNewswire Inc. • 09/06/2024 11:55:00 AM
- Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment • GlobeNewswire Inc. • 08/29/2024 08:25:00 PM
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment • GlobeNewswire Inc. • 08/21/2024 08:11:00 PM
- Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders • GlobeNewswire Inc. • 08/16/2024 08:14:00 PM
- SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug • GlobeNewswire Inc. • 08/06/2024 12:57:00 PM
- Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug • GlobeNewswire Inc. • 08/06/2024 12:57:00 PM
- Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research • GlobeNewswire Inc. • 07/31/2024 11:44:00 AM
- Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product • GlobeNewswire Inc. • 07/19/2024 11:55:00 AM
- Clearmind Medicine Obtains IND Approval from the FDA to Start the Phase I/IIa Clinical Trial with its Innovative Treatment for Alcoholism • GlobeNewswire Inc. • 07/16/2024 01:02:00 PM
- Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss • GlobeNewswire Inc. • 07/16/2024 10:03:00 AM
- SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss • GlobeNewswire Inc. • 07/16/2024 10:03:00 AM
- Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference • GlobeNewswire Inc. • 07/12/2024 12:02:00 PM
- Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment • GlobeNewswire Inc. • 06/28/2024 11:55:00 AM
- Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment • GlobeNewswire Inc. • 06/20/2024 11:57:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/13/2024 08:01:54 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM